Do you suffer from moderate to severe Crohn’s Disease?
Ehrhardt Clinical Research currently has openings for our MedImmune Crohn’s Disease study. This trial uses IV and injection medication for subjects suffering from Crohn’s Disease.
Some General Patient Selection Criteria Include:
- Male or female aged 18-80 at time of screening
- Have been diagnosed with Crohn’s Disease for at least 3 months
- Are currently experiencing symptom such as frequent stools, blood in stools and abdominal pain
- Have failed prior treatment with a biologic (such as Remicade, Humira)
- Are willing to undergo a study paid for colonoscopy
Qualified Candidates May Receive:
- Treatment by licensed and experience GI physician
- Study provided medication
- Compensation for time and travel
If you are interested in this trial, please call us at 816-318-8488 or email us at info@ecrtrials.com or complete the Volunteer Interest Form today.
